Discussing Beta Cell Preservation, Type Three Diabetes, and GLP-1 Medications

Dr. Gillett And James O'Hara NP, discuss the Semaglutide and Tirzepatide.

00:00 Intro

01:46 Why might we suggest this?

05:20 Titration schedule

06:28 Why they designed this study this way

12:04 Ai

15:35 Who should use GLP1s

17:33 Costs of GLP1s

23:35 Closing points

Studies/References:

► https://www.epicresearch.org/articles/tirzepatide-and-injectable-semaglutide-correlated-with-greatest-weight-loss-among-glp-1-medications

► https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987449/

For High-quality labs:

► https://gilletthealth.com/order-lab-panels/

For information on the Gillett Health clinic, lab panels, and health coaching:

► https://GillettHealth.com

Follow Gillett Health for more content from James and Kyle

► https://instagram.com/gilletthealth

► https://www.tiktok.com/@gilletthealth

► https://twitter.com/gilletthealth

► https://www.facebook.com/gilletthealth

Follow Kyle Gillett, MD

► https://instagram.com/kylegillettmd

Follow James O’Hara, NP

► https://Instagram.com/jamesoharanp

For 10% off Gorilla Mind products including SIGMA: Use code “GH10”

► https://gorillamind.com/

For discounts on high-quality supplements

►https://www.thorne.com/u/GillettHealth

#weightloss #podcast #ai